What was recalled
The U.S. Food and Drug Administration has issued a recall for a specific batch of prescription topical medication manufactured by Glenmark Pharmaceuticals Inc., USA. This action involves Azelaic Acid Gel at a concentration of 15%, packaged in 50-gram tubes intended strictly for topical use. The product is distributed under the brand name "Glenmark" and carries the designation "Rx only," indicating that it requires a prescription from a healthcare provider. Glenmark Pharmaceuticals, located in Elmwood Park, New Jersey, is the entity responsible for distributing these affected units nationwide across the United States. This recall was officially announced on July 23, 2026, marking a significant quality control event for this particular pharmaceutical line.
To identify whether you possess any of the recalled items, it is essential to examine the packaging and labeling with care. The product is identified by the National Drug Code (NDC) number 68462-626-52. However, the NDC alone does not determine if your specific tube is part of this recall; you must check the lot number printed on the box or the tube itself. The recall targets four specific lots, each with its own expiration date. Lot number 19260937A, which has an expiration date of February 2028, is included in this recall. Additionally, lots 19261225A and 19261185A, both expiring in March 2028, are affected. Finally, lots 19261664A and 19261682A, which expire in April 2028, are also part of the recall. If your Azelaic Acid Gel matches any of these lot numbers, it is subject to this action.
The scope of this recall is limited to the specific lots listed above and does not extend to all Glenmark Azelaic Acid Gel products. The distribution pattern covers the entire United States, meaning that patients in any state could potentially have been dispensed one of these affected tubes by a pharmacy. It is important to note that while the agency has classified this as a Class II recall, which indicates a situation where use of or exposure to the defective product may cause temporary or medically reversible adverse health consequences, the specific remedy for consumers is not currently stated in the official record. Patients who believe they have one of these lots should contact their prescribing physician or pharmacist immediately to discuss next steps, as general guidance suggests discontinuing use of any questionable topical medication until verified.
The hazard, explained
When the Food and Drug Administration flags a drug recall for Current Good Manufacturing Practice (CGMP) deviations, it is signaling that something went wrong during the production process that could affect how the medication performs or feels. In this specific case involving Glenmark Pharmaceuticals Inc., the issue centers on Azelaic Acid Gel, 15%. The core problem is not necessarily that the active ingredient is missing, but rather that the physical structure of the gel has been compromised. Consumers have reported that the product feels abnormal—specifically described as grainy, gritty, or sandy. While this might seem like a minor inconvenience compared to a chemical imbalance, it represents a significant breakdown in quality control.
To understand why this matters, it helps to look at how topical gels are designed to work. A properly manufactured gel is a uniform mixture where the active drug is evenly dispersed within a base vehicle. This consistency ensures that when you apply the gel to your skin, the medication spreads smoothly and absorbs at a predictable rate. When the texture becomes grainy or sandy, it indicates that the emulsion has likely broken down or precipitated out of solution. Physically, this means the drug particles are clumping together rather than staying suspended in the liquid base. Instead of a smooth, even layer on your skin, you are potentially applying a slurry with unevenly distributed doses.
This physical inconsistency leads to two primary risks. First, there is the risk of inconsistent dosing. If the gel is gritty, some areas of the tube may contain higher concentrations of Azelaic Acid while others contain less. This unpredictability can lead to ineffective treatment if you are not getting enough medication, or it can increase the likelihood of local skin irritation, redness, or burning if a concentrated patch of drug is applied to a sensitive area. Second, the altered texture can affect how the product interacts with your skin barrier. A gritty substance may cause micro-abrasions on the skin surface, especially if you are rubbing it in vigorously, which can compromise the skin’s natural protective layer and make it more susceptible to infection or further irritation.
While Azelaic Acid is generally well-tolerated for conditions like acne and rosacea, its efficacy relies on steady, controlled delivery. A compromised formulation undermines this goal. The "gritty" description suggests a failure in the homogenization or cooling stages of manufacturing, where temperature or mixing speeds may have been outside the strict parameters required to maintain stability. This is why the FDA classifies such deviations seriously: even if the drug itself isn't toxic, its inability to perform as designed means you are not getting the safe and effective treatment prescribed by your doctor.
Who is most at risk
When reviewing a Class II recall issued by the Food and Drug Administration, it is important to understand that "risk" in this context refers primarily to the potential for adverse health outcomes or treatment failure due to product quality deviations, rather than an immediate threat of severe injury or toxicity. In the case of Glenmark Pharmaceuticals Inc.'s Azelaic Acid Gel, 15%, the specific hazard involves CGMP (Current Good Manufacturing Practice) deviations resulting in abnormal texture. Consumers who are most directly affected by this recall are those who have been prescribed this medication for dermatological conditions such as acne vulgaris or rosacea. Because the product is distributed nationwide and is available only by prescription, the group at risk is not defined by age or demographic status in the traditional sense of physical vulnerability, but rather by their reliance on the specific lot numbers identified in the recall notice.
The individuals most likely to encounter this issue are patients who have recently filled a prescription for Azelaic Acid Gel, 15% in 50-gram tubes, specifically from the distributed lots: 19260937A (expiring February 2028), 19261225A (expiring March 2028), 19261185A (expiring March 2028), 19261664A (expiring April 2028), and 19261682A (expiring April 2028). These patients are at risk of two main issues. First, the reported texture abnormalities—described by consumers as grainy, gritty, or sandy—can make the application process unpleasant and difficult. For individuals with sensitive skin, which is common among those using prescription-strength topical acids for acne or rosacea, a gritty consistency may cause micro-abrasions or increased irritation during application, compounding the very skin sensitivity they are trying to treat.
Secondly, and perhaps more significantly, there is a risk of therapeutic failure. Azelaic acid works by penetrating the skin to reduce inflammation and kill bacteria. If the formulation’s consistency has deviated from its intended standard due to manufacturing issues, the drug may not distribute evenly across the skin surface. This uneven distribution can lead to some areas receiving too much product while others receive too little, potentially resulting in inconsistent treatment outcomes. Patients who have been relying on this medication for weeks or months may find their condition worsening not because the drug is ineffective, but because the physical delivery mechanism of the gel has been compromised.
While there are no specific high-risk demographic groups such as infants or the elderly uniquely targeted by this chemical deviation, anyone with a compromised skin barrier should exercise extra caution. Individuals with active breakouts, open lesions, or severe rosacea flare-ups may experience heightened discomfort if the gritty particles irritate broken skin. Furthermore, because the recall was announced on July 23, 2026, patients who purchased this product shortly before that date are the most likely to still have unopened or partially used tubes in their medicine cabinets. It is crucial for these individuals to check their lot numbers immediately, as the risk persists until the product is returned or destroyed.
- Patients with sensitive skin: May experience increased irritation from the gritty texture.
- Long-term users: May face inconsistent results due to uneven drug distribution.
- Individuals with open wounds or severe acne: May suffer physical discomfort from the abnormal consistency.
How to tell if you have the recalled item
Before taking any action, it is absolutely essential to confirm that your specific tube of medication matches the recall details exactly. Because this recall involves a prescription topical gel distributed by Glenmark Pharmaceuticals Inc., there are several precise identifiers you must check on your packaging. Do not rely on general descriptions like "acne cream" or "gel," as many products look similar. Instead, locate the printed information on the outer carton and the tube itself to verify the following critical data points.
First, examine the product name and concentration. The recalled item is specifically Azelaic Acid Gel, 15%. It is crucial to note that this is a prescription-only medication intended for topical use only. If your bottle says 20% or any other percentage, it is not part of this specific recall notice. Next, check the physical size of the package. The recall applies exclusively to 50 gram tubes. Other sizes, such as 30 grams or 100 grams, are not included in this batch of affected inventory.
The most reliable way to identify if your product is affected is by checking the National Drug Code (NDC) and the Lot Number. Look for the NDC printed on the box or tube. The recalled products carry the NDC 68462-626-52. If this code does not match, your product is safe from this specific recall. Below or near the NDC, you will find the Lot Number. You must cross-reference your lot number against the specific list of affected batches. The recalled lots are:
- 19260937A
- 19261225A
- 19261185A
- 19261664A
- 19261682A
In addition to the lot number, check the expiration date printed on the packaging. The recalled lots correspond to specific expiration windows:
- Lots 19260937A expire in February 2028.
- Lots 19261225A and 19261185A expire in March 2028.
- Lots 19261664A and 19261682A expire in April 2028.
If your product bears the distributor name Glenmark Pharmaceuticals Inc., USA, is located in Elmwood Park, NJ, and matches both the NDC and one of the listed lot numbers and expiration dates, it is part of this recall. If you are unsure or cannot find these details, contact your pharmacist immediately to help verify the product information.
What to do — step by step
If you have been using Glenmark Pharmaceuticals’ Azelaic Acid Gel, 15%, it is important to approach this situation with calm caution. Because the official recall announcement from the Food and Drug Administration (FDA) does not explicitly state a specific remedy—such as a mandatory return for a refund or a direct repair process—you must take the initiative to protect your health and resolve the issue. The primary concern here is not necessarily that the drug is toxic, but rather that the texture issues (described as grainy, gritty, or sandy) suggest a deviation from Current Good Manufacturing Practices (CGMP). This means the product may not be mixing correctly, which could lead to uneven dosing or physical irritation on your skin. Here is a careful, step-by-step guide on how to handle this.
- Stop using the product immediately. Even though Azelaic Acid is generally safe for treating acne and rosacea, a "gritty" or "sandy" consistency indicates that the pharmaceutical standards have not been met. You do not know if the active ingredient is distributed evenly throughout the tube. Applying it could result in applying too much of the acid to one spot (causing burns or irritation) or too little to another (rendering the treatment ineffective). Put the tube aside in a safe place where you will remember it, but do not apply it to your skin.
- Verify your lot number and expiration date. Before taking further action, confirm that you possess one of the affected batches. The recall covers specific lots distributed nationwide by Glenmark Pharmaceuticals Inc. in Elmwood Park, NJ. Check your tube for NDC 68462-626-52 and look for one of these lot numbers: 19260937A (Exp. Feb 2028), 19261225A (Exp. Mar 2028), 19261185A (Exp. Mar 2028), 19261664A (Exp. Apr 2028), or 19261682A (Exp. Apr 2028). If your lot number does not match these exactly, your product is likely safe to use, though you may still choose to monitor it.
- Contact your prescribing doctor or pharmacist. Since this is a prescription-only (Rx) medication, the most critical step is to speak with the healthcare professional who prescribed it. They need to know about the recall to update your medical records and to determine if you need a replacement from a different manufacturer or a new prescription entirely. Do not simply go back to the pharmacy and ask for a refill of the same product without checking first, as the pharmacy may have already pulled the stock.
- Reach out to Glenmark Pharmaceuticals Inc. While the recall facts do not list a direct consumer hotline or return address, you should attempt to contact the distributor directly for guidance on disposal or potential reimbursement. You can find their contact information on the packaging or through their corporate website. When you call, have your lot number and purchase date ready. Ask them specifically: "Do I need to return this tube for a refund, or is it sufficient to discard it safely?"
- Dispose of the product safely. If you cannot reach Glenmark or if they advise against keeping it, do not flush the medication down the toilet unless instructed to do so. Most pharmacies have drug take-back programs that are safe and environmentally friendly. Alternatively, you can mix the gel with an unappealing substance like coffee grounds or cat litter in a sealed bag before throwing it in the household trash to prevent anyone else from using it.
Remember, the goal here is to ensure you continue your skincare routine safely without interruption. By stopping use and consulting your doctor, you are taking the right steps to avoid any potential skin irritation or ineffective treatment caused by this manufacturing deviation.
Your refund, repair, or replacement options
When you receive a notification about a product recall, your immediate concern is often financial: "How do I get my money back?" or "Will I get a working replacement instead?" It is completely normal to feel anxious about this step, but understanding the process can help reduce that stress. In this specific case involving Glenmark Pharmaceuticals Inc., the situation is somewhat unique because the official recall facts provided by the FDA do not explicitly state a standard remedy such as a full refund, a repair service, or a direct replacement product. This absence of stated terms does not mean you are left without recourse; rather, it means you must take proactive steps to initiate the resolution process yourself. The primary reason for this gap in the public record is often that the manufacturer handles customer remediation through private channels before or alongside public announcements. Since the recall notice lists Glenmark Pharmaceuticals Inc., located in Elmwood Park, New Jersey, as the distributor, they are the entity responsible for honoring any financial guarantees associated with this purchase. You should not assume that your pharmacist or the retail store where you bought the medication will automatically process a refund. While they may be helpful, their systems often require specific authorization codes or direct communication with the manufacturer’s quality assurance department to reverse a transaction for a recalled drug item. To secure a refund or potentially receive a corrected batch of Azelaic Acid Gel, 15%, you need to gather your evidence first. Locate your original prescription receipt, which should list the lot numbers mentioned in the recall: 19260937A, 19261225A, 19261185A, 19261664A, or 19261682A. If you have lost your receipt, do not panic; your pharmacy records usually retain this information for years. Contact the pharmacy where you filled the prescription and ask them to verify the lot number and date of dispensing. This verification is crucial because it proves that the specific units in question were part of the nationwide distribution pattern affected by the CGMP deviations regarding texture and consistency. Next, you must reach out to Glenmark Pharmaceuticals Inc. directly. Since the recall facts do not provide a dedicated toll-free hotline or a web form for this specific 2026 recall, your best initial step is to call the pharmacy’s customer service line and ask them to connect you with the manufacturer’s consumer affairs or quality assurance department. Alternatively, you can visit the Glenmark Pharmaceuticals website and look for their "Contact Us" or "Patient Support" section. When you speak with a representative, clearly state that you are holding product subject to the July 23, 2026, FDA recall due to abnormal texture (grainy or gritty consistency). Ask specifically about their current policy for this event: do they offer store credit, a direct refund to your original payment method, or a shipment of new, non-defective gel? It is important to act promptly. While the expiration dates for these lots range from February 2028 to April 2028, indicating the product was not yet old, the quality deviation makes it unsuitable for use. Manufacturers often have time-limited windows for claiming refunds or replacements for recalled items. Do not dispose of the product until you have received explicit instructions from Glenmark Pharmaceuticals or your pharmacist on how to return it safely. Keeping the original packaging intact helps identify the NDC number (68462-626-52) and lot codes, which speeds up the verification process significantly. By taking these organized steps, you ensure that you are not left paying for a product that failed to meet safety and quality standards.What can happen if you ignore it
When a product recall involves a medical treatment like Azelaic Acid Gel, the decision to continue using a recalled item often feels like a minor inconvenience rather than a health crisis. It is easy to think, "It’s just a little texture change," or "I have so much left, I don’t want to waste it." However, ignoring a Class II recall from the FDA is not merely about wasting money; it is about compromising the integrity of a treatment designed to manage skin conditions. The Glenmark Pharmaceuticals recall centers on specific deviations from Current Good Manufacturing Practices (CGMP), resulting in products with abnormal textures described as grainy, gritty, or sandy. While this may seem like a superficial cosmetic defect, it signals that the chemical and physical stability of the gel has been compromised in ways that are not immediately visible but are physically present.
The primary risk of continuing to use this gel lies in the unpredictability of drug delivery. Azelaic acid is an active pharmaceutical ingredient that must be dispersed evenly within its carrier base to ensure you receive the correct dosage with each application. When the consistency becomes gritty or sandy, it indicates that the emulsion has broken down or that particulate matter has formed inconsistently throughout the tube. This means that one application might deliver a safe, therapeutic dose, while the next application from the same tube could deliver a significantly higher concentration of active ingredient in a single spot, or conversely, leave you under-dosed because the drug has settled at the bottom. For individuals using this medication for acne or rosacea, inconsistent dosing can lead to ineffective treatment, allowing skin conditions to worsen or fail to improve as expected.
Beyond efficacy, there is a tangible physical risk associated with applying a gritty substance to compromised skin. Azelaic acid itself can cause mild irritation, redness, or dryness during the initial stages of use. When combined with an abnormal, abrasive texture, the risk of mechanical irritation increases. If you are using this gel for active acne lesions, rosacea with visible broken capillaries, or other inflammatory conditions, your skin barrier is already sensitive. Rubbing gritty particles across inflamed skin can cause micro-tears, increase friction-induced redness, and potentially introduce bacteria into compromised tissue. This mechanical irritation can mask the symptoms of an allergic reaction or contact dermatitis, making it difficult to determine whether a flare-up is due to the medication itself or the physical abrasion of the defective product.
Furthermore, there is the risk of unknown chemical degradation. While the recall notice specifically cites texture issues, deviations in manufacturing processes that cause graininess can sometimes be accompanied by changes in pH levels or the formation of unintended byproducts. Using a topical medication that has deviated from its certified formula means you are exposing your skin to an unverified chemical environment. The FDA classifies this as a Class II recall because it is not immediately life-threatening, but it does pose a substantial risk to health if used without correction. Ignoring the recall denies you the opportunity to get a safe, effective replacement and leaves you treating your skin with a product that no longer meets the rigorous standards required for pharmaceutical safety.
- Inconsistent Treatment Results: You may find your skin condition does not improve because the active ingredient is not being delivered evenly.
- Increased Skin Irritation: The gritty texture can physically abrade sensitive or inflamed skin, worsening redness and discomfort.
- Masked Reactions: Physical irritation from the defect may be mistaken for a normal side effect of the drug, delaying proper medical attention.
Staying safe: broader tips
When dealing with topical prescription medications like azelaic acid gel, your safety begins long before you apply the first dose. Because these products are designed to alter the skin’s surface and manage conditions such as acne or rosacea, maintaining their integrity is crucial for both efficacy and hygiene. One of the most effective ways to protect your health is to store your medications exactly as directed on the label. Generally, this means keeping them at room temperature in a dry place, away from direct sunlight and humidity. Bathrooms, despite being convenient, are often poor storage spots because the steam from showers can degrade the chemical stability of many gels and creams. By storing your medication in a cool, dry cabinet or drawer, you help preserve its consistency and potency, ensuring that it works as intended without breaking down prematurely.
Another vital habit is to regularly inspect your products before use. While this recall highlights issues with texture, you should always check for any unusual changes in color, odor, or separation of ingredients. If a product looks different than when you first opened it, or if the application feels gritty or uneven, it is wise to stop using it immediately. Do not assume that a slight change is normal; when in doubt, consult your pharmacist or healthcare provider. They can help determine if the product is still safe or if it needs to be replaced. This proactive approach helps prevent potential skin irritation or reduced treatment effectiveness.
Finally, stay informed about medication recalls by signing up for alerts from reliable sources like the FDA’s website or your pharmacy’s notification system. Recalls are often initiated to prevent minor issues from becoming major health concerns. By staying aware of current recalls and understanding which batches might be affected, you can act quickly if your medication is involved. Remember, while most products are safe when used correctly, vigilance is your best defense against unexpected quality issues. Regularly reviewing your medicine cabinet and discussing any concerns with your healthcare team ensures that you remain in control of your health journey.